Malalasiya Medical Case

Great Essays
Should The Pharmaceutical Industry Provide Free Medication To Those Who Cannot Afford It?
Raghavendra Appalla #1675363
Fairleigh Dickinson University
EPS 8109_8P

Abstract
In this paper the importance of free medication is explained clearly in this paper.In this paper the various aspects like intellectual property,finance drug development and the development on framework for essential drugs distribution.In this paper all the above aspects are analyzed and then these are supported with an example regarding Malasiya’s case study with the affordability,cost,availability and pricing of drugs.A new set of ideas and proposals have been discussed thorughly which would lead to the availability of drugs in huge amounts with the contribution
…show more content…
This states that even though the drugs are available with the pharamecitucal industries to provide with free medication they are not willing to provide as they believe that by doing so in such manner they felt that it would be a violation of intellectual property and would seriously be taken into action. If there was certain relaxation on such type of issues then perhaps many people would have been saved from the epidemic despite they all fell as a prey to this deadly disease. The other step to provide free nedication would be classification of drug categories into a separate category called the essential drugs.
“The position of pharmaceutical industry in a highly competitive global market has turned drugs from public health tool to a commodity”( Dyann Wirth,2002,pg.5)this has widely effected the world health conditions and need for now is to make the drugs which are life saving as essential drugs.For the drugs to be classified in such manner the should be combined efforts from the pharmaceutical companies and also the governing
…show more content…
References
Trouiller, P., Torreele, E., & Foster, S. (2002). Drugs for neglected diseases: A failure of the market and a public health failure? Tropical Medicine &International Health, 6(11), 4-4.
Singh, H., Creese, A., & Foster, S. (2007). Evaluating Drug Prices, Availability, Affordability, and Price Components: Implications for Access to Drugs in Malaysia. PLOS Medicine, 4(3), 1,3-1,3.
Henry, D., & Lexchin, J. (16 Novembe). The pharmaceutical industry as a medicines provider (Vol. 360, pp. 1590-1595). Retrieved from http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(02)11527-3/fulltext.
Trouille, P. (Jan 27 ). Access to Essential Drugs in Poor Countries A Lost Battle? (4th ed., Vol. 281, pp. 1590-1595). Retrieved from

Related Documents

  • Decent Essays

    Increasing expenses of medications in Canada. Outline Mullin, A. (2015). It is time for a universal drug plan? U of T Magazine.…

    • 235 Words
    • 1 Pages
    Decent Essays
  • Improved Essays

    In David Badcott’s position paper “Big Pharma: A Former Insider’s View,” Badcott makes the assumption that the future of healthcare will predominately focus on the administration pharmaceutical drugs, which is not true because drugs can cause complications in individuals and thus require medical attention from healthcare practitioners. Badcott implies that the services of healthcare professionals will become obsolete. This implication is not true because there are healthcare services that do not primarily focus on treatment with medicinal drugs. Although pharmaceutical drugs play a huge role in the current healthcare industry, the role of the medical practitioner is as equally important. Badcott states the effectiveness of newer pharmaceutical drugs allow for the reduction of “total health expenditures by lowering the need for other types of medical services” (Badcott 252).…

    • 706 Words
    • 3 Pages
    Improved Essays
  • Superior Essays

    Allowing a drug company to have a monopoly where it can charge whatever it can force the individual, or more typically the insurer or the government, to pay makes little sense” (Baker). Medical pharmaceuticals are perfectly inelastic, meaning that at any price,…

    • 1507 Words
    • 7 Pages
    Superior Essays
  • Decent Essays

    From the labelling perspective, different social class are vulnerable to being differently labelled which applies to mental illness. Illnesses have both biomedical and experiential dimensions Marxist states that ill-health is caused by either random attract of disease or individual lifestyle. Individual is blamed when social influence causes their health in unequal society such as low income, un-employment, and hazard work places. The health services also help to keep the work force fit and the doctors are agent of social control. Medication is mainly concerned with providing capitalist with healthy workforce.…

    • 208 Words
    • 1 Pages
    Decent Essays
  • Improved Essays

    The Wall Street Journal writer, Drew Altman, states that “seventy-six percent of the public blames drug companies for high drug prices – with just ten percent blaming insurers” (Altman). Since the main buyers of medications are private insurers and the federal government, the pricing decision commonly does not consider the patient’s affordability. Pharmaceutical firms such as Medicare are not allowed to discuss prices with manufacturers while the Food and Drug Administration (FDA) does not consider cost in medication approval at all. Rare value and lack of alternatives influence high costs and “although some price increases have been caused by shortages, others have resulted from a business strategy of buying old neglected drugs and turning them into high-priced ‘specialty drugs’” (Pollack).…

    • 727 Words
    • 3 Pages
    Improved Essays
  • Improved Essays

    Most Canadians have come to think very highly of their universal health-care system since it was established nationwide almost 50 years ago. But for all its benefits, it doesn’t cover every health-related cost: medications outside hospital, for example, are exempt. Why? The commonly cited reason is that they would be too costly to include. But a study involving U of T researchers suggests a nationwide “pharma care” program could save Canadians billions of dollars, without costing governments much more, if anything.…

    • 550 Words
    • 3 Pages
    Improved Essays
  • Great Essays

    To which the general public will buy their medications from. “They are accusing 22 drug manufacturers of illegally conspiring to fix prices by offering discounts to health maintenance organizations and others but not to retail pharmacies.” “Freudenheim,…

    • 1968 Words
    • 8 Pages
    Great Essays
  • Improved Essays

    The Food and Drug Administration Big markets need standards to achieve success. Otherwise, without substantial control, markets fail due to poor quality. The bad quality of food and drugs may result in the death or illness of people. In 1937, a drug called Elixir Sulfanilamide poisoned and caused 100 deaths in the US which led to the passing of The Food and Drug Administration Act of 1938. The Food and Drug Administration works to minimize the adverse effects of food and drugs.…

    • 414 Words
    • 2 Pages
    Improved Essays
  • Improved Essays

    For example, when it comes to spending on Type 2 diabetes drugs by private insurance plans in Canada, 30 percent of the time doctors prescribed vastly more expensive drugs without first trying cheaper alternatives. (pg. 8) Hence, it shows that the high spending’s on diabetes medication has resulted in the diabetes association of Canada to first prescribe generic drugs like Metformin. This diabetes medication only costs $65 per year.…

    • 895 Words
    • 4 Pages
    Improved Essays
  • Improved Essays

    Over Medicated Essay

    • 512 Words
    • 3 Pages

    Last year, pharmacist filled 4,468,929,929 prescriptions in the United States that is an 85 percent increase from just twenty years earlier (Carr, Rabkin, and Skinner 38). With these kinds of numbers, it must be obvious the process to develop drugs in America is working like a well-oiled machine, or is it? Prescription drug companies, the Food and Drug Administration (FDA) and independent research companies including universities all work together to develop improved medications. Each one has an unbiased, independent role to play in the process, however, over the years the unbiased independent part has become blurred. The Federal Government has made changes to regulations and health care policies, consequently, the prescription drug company’s…

    • 512 Words
    • 3 Pages
    Improved Essays
  • Improved Essays

    compensate and support these elevated drug costs via increasing premiums (“The high prices of prescription drugs,” n.d.). Digging deeper in the mindset of the drug companies, they exploit the blend of regulations that oblige insurance companies to incorporate fundamentally all of the costly medications in their policies (“The high prices of prescription drugs,” n.d.). They also use the logic and mantra that really stipulates that each novel health care good be accessible to the masses (“The high prices of prescription drugs,” n.d.). This is regardless of how much the cost is or if it has little effect on patient outcomes (“The high prices of prescription drugs,” n.d.).…

    • 348 Words
    • 2 Pages
    Improved Essays
  • Improved Essays

    If this matters, it will bring more fear to the humanity also reducing a global welfare. TRIPS didn’t provide a research and development capabilities between industrialized countries and poor countries (Lanoszka, 2003). Affordable medicines is an important concern for developing countries, while TRIPS agreements seem to be a prevention for a provision of public health due by restriction to availability and a difficulty of access with patent owners or even producers in rich countries (Hoekman and Kostecki, 2009).It makes difficulties for developing countries to build its pharmaceutical industries because the prevention of imitation. As we know that at that time, there is a lack of capabilities of poor countries to produce some medicine by…

    • 1129 Words
    • 5 Pages
    Improved Essays
  • Improved Essays

    Due to India patients being poor and the country being undeveloped, these laws were created. Studies showed during this time, that patients in India were paying more for medications than patients in the United States and European countries. Due to these findings, the…

    • 778 Words
    • 4 Pages
    Improved Essays
  • Improved Essays

    The core of the pharmaceutical industry problems consists of the expiration of patents, rising R&D expenses, and uncertainties facing new researched products and their abnormal methods of circulation of returns from said product. As rooted in the topic of this case AstraZeneca upholds the gold of innovatively changing the way medicine reaches patients. When patents are first granted there are procedures that followed before a drug reaches the marketplace. Due to the extended timeframe that is required for clinical trials, studies and organizational processes to tested and developed the revenue phase of the drug decreases (Hitt, Ireland, & Hoskisson, 2015). More specifically after the developed drug is ready for sale the patent remaining on these products are near expiration.…

    • 703 Words
    • 3 Pages
    Improved Essays
  • Great Essays

    TRIPs only enabled countries with major public health concerns to issue CL for the manufacture of patent protected medicines in their own territory (Ashurst 2006, p 1-2.). However in 2001, developing countries were concerned with the narrow approach of the TRIPS agreement which led to further talks and initiation of the Doha Declaration 2001 which focuses on clarifying the scope of TRIPS and promoting access to medicines for all. TRIPS agreements have been criticized implying CL are near impossible to exercise and additionally lengthy patent periods for TRIPS have been slowing entry of generics to the markets and perceived as growing the multinational companies in developed countries rather than promoting growth in developing countries which can ultimately lead to reduced access to ST. Systematic issuance of CLs can set negative precedent, lead to overuse and reduce incentive to invest in the R&D of new medicines that address unmet medical needs (Chatterjee 2013, p.…

    • 1219 Words
    • 5 Pages
    Great Essays